Chicago IL 镰状细胞病临床试验
18项针对 镰状细胞病的研究正在 Chicago及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
招募中1 期
- University of Illinois Hospital and Health Sciences System, Chicago
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
招募中3 期
- Uni of Illinois Hospital and HSC, Chicago
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
招募中3 期
- University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
招募中
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
招募中2 期
- University of Illinois at Chicago, Chicago
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
招募中1 期
- University of Illinois at Chicago College of Medicine, Chicago
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
招募中3 期
- Univer Of Illinois at Chicago, Chicago
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
招募中3 期
- Childrens Hospital of Chicago, Chicago
- Univer Of Illinois at Chicago, Chicago
Tocilizumab for Acute Chest Syndrome
招募中2 期
- University of Chicago, Chicago
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
招募中2/3 期
- University of Illinois at Chicago Clinical Research Center, Chicago
- University of Illinois Hospital and Health Sciences System - Investigational Drug Services (IDS), Chicago
- University of Illinois Hospital and Health Sciences System, Chicago
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
招募中1/2 期欢迎健康志愿者
- Local Institution - 0034, Chicago
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
招募中观察性研究
- Rush University Medical Center, Chicago
Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
招募中2 期
- University of Illinois at Chicago, Chicago
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
招募中观察性研究
- Comer Children's Hospital (MRD-HCT), Chicago
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
招募中2 期
- University of Illinois Chicago, Sickle Cell Center, Chicago
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
招募中
- University of Illinois at Chicago, Chicago
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
招募中2 期
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
招募中观察性研究
- University of Illinois, Chicago
其他城市的 镰状细胞病试验
- Washington, DC21 项研究
- Atlanta, GA20 项研究
- Memphis, TN19 项研究
- New York City, NY16 项研究
- Philadelphia, PA15 项研究
- Birmingham, AL14 项研究
- Houston, TX12 项研究
- Boston, MA12 项研究
- St. Louis, MO12 项研究
- Durham, NC10 项研究
- Cincinnati, OH10 项研究
- Greenville, NC9 项研究
Chicago的其他研究
- 乳腺癌59 项研究
- 非小细胞肺癌59 项研究
- 癌症（所有类型）51 项研究
- 前列腺癌45 项研究
- 肺癌43 项研究
- 转移性癌症42 项研究
- 肥胖症40 项研究
- 卵巢癌36 项研究
- 结直肠癌32 项研究
- 卒中31 项研究
- 头颈鳞状细胞癌29 项研究
- 超重29 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。